Carboplatin plus paclitaxel in the successful treatment of advanced inflammatory myofibroblastic tumor

Naoki Kubo, Taishi Harada, Satoshi Anai, Kohei Otsubo, Yasuto Yoneshima, Kayo Ijichi, Takaomi Koga, Koichi Takayama, Yoichi Nakanishi

Research output: Contribution to journalArticlepeer-review

18 Citations (Scopus)

Abstract

A 26-year-old man with unresectable inflammatory myofibroblastic tumor (IMT) presented with multiple metastases in the thoracic vertebra and lymph nodes as detected by positron emission tomography (PET) received chemotherapy with carboplatin plus paclitaxel. After three cycles of chemotherapy, fluorine-18-fluorodeoxyglucose (FDG)-PET/CT revealed tumor regression and significant reduction of FDG uptake in all lesions. The patient received six cycles of chemotherapy without any severe adverse event, and there was no sign of disease progression for seven months. This regimen is well tolerated and may be considered the treatment of choice for unresectable IMT.

Original languageEnglish
Pages (from-to)2399-2401
Number of pages3
JournalInternal Medicine
Volume51
Issue number17
DOIs
Publication statusPublished - 2012

All Science Journal Classification (ASJC) codes

  • Internal Medicine

Fingerprint

Dive into the research topics of 'Carboplatin plus paclitaxel in the successful treatment of advanced inflammatory myofibroblastic tumor'. Together they form a unique fingerprint.

Cite this